These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9262943)

  • 1. Quantitative structure-activity relationships in substrates, inducers, and inhibitors of cytochrome P4501 (CYP1).
    Lewis DF
    Drug Metab Rev; 1997 Aug; 29(3):589-650. PubMed ID: 9262943
    [No Abstract]   [Full Text] [Related]  

  • 2. Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families.
    Lewis DF
    Curr Med Chem; 2003 Oct; 10(19):1955-72. PubMed ID: 12871098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring structure-activity relationships of mutagens and carcinogens.
    Benigni R
    Prog Clin Biol Res; 1991; 372():59-67. PubMed ID: 1956948
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactive metabolites of 1,3-butadiene: DNA and hemoglobin adduct formation and potential roles in carcinogenicity.
    Elfarra AA; Moll TS; Krause RJ; Kemper RA; Selzer RR
    Adv Exp Med Biol; 2001; 500():93-103. PubMed ID: 11765021
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes.
    Hollenberg PF
    Drug Metab Rev; 2002; 34(1-2):17-35. PubMed ID: 11996009
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver.
    Shimada T; Okuda Y
    Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mutagens by human cytochrome P-450 enzymes.
    Guengerich FP; Shimada T; Iwasaki M; Martin MV
    Prog Clin Biol Res; 1990; 340B():87-96. PubMed ID: 2168051
    [No Abstract]   [Full Text] [Related]  

  • 8. A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation.
    Islam SA; Wolf CR; Lennard MS; Sternberg MJ
    Carcinogenesis; 1991 Dec; 12(12):2211-9. PubMed ID: 1747920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochromes P-450 and the activation and inactivation of mutagens and carcinogens.
    Strobel HW; Fang WF; Takazawa RS; Stralka DJ; Newaz SN; Kurzban GP; Nelson DR; Beyer RS
    Basic Life Sci; 1986; 39():61-71. PubMed ID: 3094496
    [No Abstract]   [Full Text] [Related]  

  • 10. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.
    Rendic S; Di Carlo FJ
    Drug Metab Rev; 1997; 29(1-2):413-580. PubMed ID: 9187528
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of support vector machines to in silico prediction of cytochrome p450 enzyme substrates and inhibitors.
    Yap CW; Xue Y; Li ZR; Chen YZ
    Curr Top Med Chem; 2006; 6(15):1593-607. PubMed ID: 16918471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
    Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
    Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical study on the role of different types of microsomal cytochrome P-450 in mutagenesis by chemical carcinogens.
    Kawajiri K; Yonekawa H; Harada N; Noshiro M; Omura T; Tagashira Y
    Cancer Res; 1980 May; 40(5):1652-7. PubMed ID: 6768451
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytochrome P-450 and the activation of promutagens in Saccharomyces cerevisiae.
    Callen DF; Philpot RM
    Mutat Res; 1977 Dec; 45(3):309-24. PubMed ID: 339069
    [No Abstract]   [Full Text] [Related]  

  • 16. [The participation of cytochrome P-450 in the formation of mutagenic and carcinogenic compounds and the use of this property in preventive medicine].
    Friedrich J; Pfeil D
    Pharmazie; 1985 Apr; 40(4):228-32. PubMed ID: 3892552
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytochrome P450 enzymes in chickens: characteristics and induction by xenobiotics.
    Gupta RP; Abou-Donia MB
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Nov; 121(1-3):73-83. PubMed ID: 9972452
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of cytochrome P-450 and metabolic activation of mutagens in the rat ventral prostate.
    Gustafsson JA; Söderkvist P; Haaparanta T; Busk L; Pousette A; Glaumann H; Toftgård R; Högberg B
    Prog Clin Biol Res; 1981; 75B():191-205. PubMed ID: 7323096
    [No Abstract]   [Full Text] [Related]  

  • 19. P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer.
    Nedelcheva V; Gut I
    Xenobiotica; 1994 Dec; 24(12):1151-75. PubMed ID: 7771104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of carcinogens by human liver cytochromes P-450.
    Guengerich FP; Shimada T; Iwasaki M; Butler MA; Kadlubar FF
    Basic Life Sci; 1990; 53():381-96. PubMed ID: 2282045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.